Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research

Pharmacology and Therapeutics

Volumn 109, Issue 1-2, 2006, Pages 274-283

  Semplicini, Andrea ^a,j   Amodio, Piero ^a   Leonetti, Gastone ^c   Cuspidi, Cesare ^d   Umiltà, Carlo ^a   Schiff, Sami ^a   Scheltens, Philip ^g   Barkhof, Frederik ^g   Emanueli, Costanza ^e,f   Cagnin, Annachiara ^b   Pizzolato, Gilberto ^a   Macchini, Luisa ^a   Realdi, Anna ^a   Royter, Vladimir ^h   Bornstein, Natan M ^h   Madeddu, Paolo ^e,f,i  

^a UNIVERSITY OF PADOVA   (Italy)

^b Brain Aging Center   (Italy)

^c Ospedale S Luca   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^f UNIVERSITY OF SASSARI   (Italy)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j UNIVERSITY HOSPITAL OF PADOVA   (Italy)

more..

Author keywords

Antihypertensive drug therapy; Arterial hypertension; Clinical trials; Cognitive impairment; Vascular dementia

Indexed keywords

ACETAZOLAMIDE; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; KALLIKREIN; NEUROTROPHIN; OXYGEN 15; TECHNETIUM 99M; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN; VASCULOTROPIN A; XENON 133;

ARTERY INTIMA; ARTERY MEDIA; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN FUNCTION; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; COGNITIVE DEFECT; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM RESPONSE; GLUCOSE METABOLISM; HUMAN; LONGITUDINAL STUDY; MEDICAL RESEARCH; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASOSPASM; WORKING MEMORY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; COGNITION DISORDERS; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 28444487433     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.08.010     Document Type: Review

References (85)

1. E. Alonso-Prieto, M.A. Alvarez-Gonzalez, A. Reyes-Verazain, O. Fernandez-Concepcion, E. Barros-Garcia, and A. Pando-Cabrera Uso de potenciales relacionados con eventos para el diagnostico y seguimiento de los trastornos subclinicos de la atencion sostenida en la enfermedad cerebrovascular isquemica Rev Neurol 34 2002 1017 1020
2. A. Aotsuka, S.J. Weate, M.E. Drake Jr., and G.W. Paulson Event-related potentials in Parkinson's disease Electromyogr Clin Neurophysiol 36 1996 215 220
3. W.B. Applegate, S. Pressels, and I. Witters Impact of the treatment of isolated systolic hypertension on behavioural variables: results from the systolic hypertension in elderly program Arch Intern Med 154 1994 2154 2160
4. A. Auperin, C. Berr, C. Bonithon-Kopp, P.J. Touboul, I. Ruelland, and P. Ducimetiere Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds Stroke 27 1996 1290 1295
5. R. Barber, A. Gholkar, C. Ballard, P. Scheltens, I. McKeith, and R. Perry White matter lesions on MRI in dementia with Lewy bodies, Alzheimer's disease, Vascular dementia and normal ageing J Neurol Neurosurg Psychiatry 67 1999 66 72
6. N.M. Bornstein, A.Y. Gur, T.A. Treves, I. Reider-Groswasser, B.D. Aronovich, and S.S. Klimovitzky Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke 27 1996 904 905
7. M.M.B. Breteler, J.J. Claus, D.E. Grobbee, and A. Hofman Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study BMJ 308 1994 1604 1608
8. M.M. Breteler, J.C. van Swieten, M.L. Bots, D.E. Grobbee, J.J. Claus, and J.H. van den Hout Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study Neurology 44 1994 1246 1252
9. R.D. Brown, J.P. Whisnant, J.D. Sicks, W.M. O'Fallon, and D.O. Wiebers Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989 Stroke 27 1996 373 380
10. H. Bruunsgaard, K. Andersen-Ranberg, B. Jeune, A.N. Pedersen, P. Skinhoj, and B.K. Pedersen A high plasma concentration of TNF-alpha is associated with dementia in centenarians J Gerontol Ser A Biol Sci Med Sci 54 1999 357 364
11. L. Calza, L. Giardino, A. Giuliani, L. Aloe, and R. Levi-Montalcini Nerve growth factor control of neuronal expression of angiogenic and vasoactive factors Proc Nat Acad Sci U S A 98 2001 4160 4165
12. J.R. Cerhan, A.R. Folsom, J.A. Mortimer, E. Shahar, D.S. Knopman, and P.G. McGovern Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators Gerontology 44 1998 95 105
13. H.H. Chen, C.H. Chien, and H.M. Liu Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct Stroke 25 1994 1651 1657
14. S.J. Cho, Y.H. Sohn, G.W. Kim, and J.S. Kim Blood flow velocity changes in the middle cerebral artery as an index of the chronicity of hypertension J Neurol Sci 150 1997 77 80
15. S.E. Counts, M. Nadeem, J. Wuu, S.D. Ginsberg, H.U. Saragovi, and E.J. Mufson Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease Ann Neurol 56 2004 520 531
16. C. De Carli Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment Lancet Neurol 2 2003 15 21
17. J.C. De Groot, F.E. de Leeuw, M. Oudkerk, A. Hofman, J. Jolles, and M.M. Breteler Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study Neurology 56 2001 1539 1545
18. F.E. De Leeuw, J.C. de Groot, M. Oudkerk, J.C. Witteman, A. Hofman, and J. van Gijn A follow-up study of blood pressure and cerebral white matter lesions Ann Neurol 46 1999 827 833
19. A. De Luigi, S. Pizzimenti, P. Quadri, U. Lucca, M. Tettamanti, and C. Fragiacomo Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia Neurobiol Dis 11 2002 308 314
20. C.P. Derdeyn, R.L. Grubb, and W.J. Poers Cerebral hemodynamic impairment. Methods of measurement and association with stroke risk Neurology 53 1999 251 259
21. C. Emanueli, M.B. Salis, A. Pinna, G. Graiani, L. Manni, and P. Madeddu Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs Circulation 106 2002 2257 2262
22. S.J. Fearn, S. Hutchinson, G. Riding, G. Hill-Wilson, K. Wesnes, and C.N. McCollum Carotid endarterectomy improves cognitive function in patients with exhausted cerebrovascular reserve Eur J Vasc Endovasc Surg 26 2003 529 536
23. A. Ficzere, A. Valikovics, B. Fülesdi, A. Juhász, I. Czuriga, and L. Csiba Cerebrovascular reactivity in hypertensive patients: a transcranial Doppler study J Clin Ultrasound 25 1997 383 389
24. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, M.R. Babarskiene, S. Babeanu Systolic Hypertension in Europe Investigators Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study Arch Intern Med 162 2002 2046 2052
25. G.B. Frisoni, S. Galluzzi, L. Bresciani, O. Zanetti, and C. Geroldi Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome J Neurol 249 2002 1423 1432
26. A.Y. Gur, I. Bova, and N.M. Bornstein Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke 27 1996 2188 2190
27. O. Hanon, M.L. Seux, H. Lenoir, A.S. Rigaud, and F. Forette Hypertension and dementia Curr Cardiol Rep 5 2003 435 440
28. C. Heeschen, S. Dimmeler, C.W. Hamm, E. Boersma, A.M. Zeiher, and M.L. Simoons Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes Circulation 107 2003 524 530
29. C. Huang, L.O. Wahlund, T. Dierks, P. Julin, B. Winblad, and V. Jelic Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross sectional and longitudinal study Clin Neurophysiol 111 2000 1961 1967
30. K. Imamura, N. Hishikawa, K. Ono, H. Suzuki, M. Sawada, and T. Nagatsu Cytokine production of activated microglia and decrease in eurotrophic factors of neurons in the hippocampus of Lewy body disease brains Acta Neuropathol (Berl) 109 2005 141 150
31. J.R. Jennings, M.F. Muldoon, C.M. Ryan, M.A. Mintun, C.C. Meltzer, and D.W. Townsend Cerebral blood flow in hypertensive patients. An initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks Hypertension 31 1998 1216 1222
32. D.L. Jonas, J.A. Blumental, D.J. Madden, and M. Serra Cognitive consequences of antihypertensive medications S.R. Waldstein M.F. Elias Neuropsychology of Cardiovascular Disease 2001 Erlbaum Mahwah, NJ 167 188
33. P. Kapeller, R. Barber, R.J. Vermeulen, H. Ader, P. Scheltens, and W. Freidl Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements Stroke 34 2003 441 445
34. T. Kawamata, E.K. Speliotas, and S.P. Finklestein The role of polypeptide growth factors in recovery from stroke Adv Neurol 73 1997 377 382
35. C.S. Kidwell, S. El-Saden, Z. Livshits, N.A. Martin, T.C. Glenn, and J.L. Saver Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease J Neuroimaging 11 2001 229 235
36. H. Lithell, L. Hansson, I. Skoog, D. Elmfeldt, A. Hofam, and B. Olofsson The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomized double-blind intervention trial J Hypertens 21 2003 875 886
37. C. Messa, D. Perani, G. Lucignani, A. Zenorini, F. Zito, and G. Rizzo High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET J Nucl Med 35 1994 210 216
38. S. Monsell, and J. Driver Control of cognitive processes: attention and performance XVIII 2000 MIT Press Cambridge, MA
39. S.H. Mostofsky, J.G.B. Schafer, M.T. Abrams, M.C. Golberg, A.A. Flower, and A. Boyce fMRI evidence that the neural basis of response inhibition is task-dependent Cogn Brain Res 17 2003 419 430
40. J. O'Brien, R. Perry, R. Barber, A. Gholkar, and A. Thomas The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms Ann N Y Acad Sci 903 2000 482 489
41. J.T. O'Brien, T. Erkinjuntti, B. Reisberg, G. Roman, T. Sawada, and L. Pantoni Vascular cognitive impairment Lancet Neurol 2 2003 89 98
42. M. Oishi, and Y. Mochizuki Correlation between contingent negative variation and regional cerebral blood flow Clin Electroencephalogr 29 1998 124 127
43. 99mTc, HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia Eur J Nucl Med 26 1999 239 245
44. S. Peng, J. Wuu, E.J. Mufson, and M. Fahnestock Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease J Neuropathol Exp Neurol 63 2004 641 649
45. P. Porcu, C. Emanueli, E. Desortes, G.M. Marongiu, F. Piredda, and L. Chao Circulating tissue kallikrein levels correlate with severity of carotid atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 1104 1110
46. L.S. Prichep, E.R. John, S.H. Ferris, B. Reisberg, M. Almas, and K. Alper Quantitative EEG correlates of cognitive deterioration in the elderly Neurobiol Aging 15 1994 85 90
47. M.J. Prince, A.S. Bird, and R.A. Blizard Is the cognitive functional of older patients affected by antihypertensive treatment? Results from 54-months of the Medical Research Councils treatment trials of hypertension in older adults Br Med J 312 1996 801 805
48. B. Rapp Handbook of cognitive neuropsychology 2001 Psychology Press New York
49. A. Realdi, V. Mascagna, L. Ciccariello, L. Macchini, V. Benetton, and F. Del Piccolo Impaired cerebral vasoreactivity in hypertensives: an early marker of vascular dementia? J Hypertension 21 Suppl 4 2003 S166
50. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
51. G.C. Roman, T. Erkinjuntti, A. Wallin, L. Pantoni, and H.C. Chui Subcortical ischaemic vascular dementia Lancet Neurol 1 2002 426 436
52. N.S. Rost, P.A. Wolf, C.S. Kase, M. Kelly-Hayes, H. Silbershatz, and J.M. Massaro Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study Stroke 32 2001 2575 2579
53. V. Royter, and S.N. Cohen Know your options for assessing cerebrovascular reserve Pract Neurol 3 2004 63 67
54. M.D. Rugg, and M.G.H Coles Electrophysiology of mind: event-related brain potentials and cognition 1995 Oxford Univ. Press London
55. O. Sabri, E.B. Ringelstein, D. Hellwig, R. Schneider, M. Schreckenberger, and H.J. Kaiser Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy Stroke 30 1999 556 566
56. H. Sattel, H. Forstl, and S. Biedert Senile dementia of Alzheimer-type and muli-infarct dementia investigated by transcranial Doppler sonography Dementia 7 1996 41 46
57. B.K. Saxby, F. Harrington, I.G. McKeith, K. Wesnes, and G.A. Ford Effects of hypertension on attention, memory, and executive function in older adults Health Psychol 22 2003 587 591
58. P. Scheltens, F. Barkhof, J. Valk, P.R. Algra, R. Gerritsen van der Hoop, and J.J.P. Nauta White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: evidence for heterogeneity Brain 115 1992 735 748
59. P. Scheltens, T. Erkinjunti, D. Leys, L.O. Wahlund, D. Inzitari, and T. del Ser White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes Eur Neurol 39 1998 80 89
60. R. Schmidt, G. Roob, P. Kapeller, H. Schmidt, A. Berghold, and A. Lechner Longitudinal change of white matter abnormalities J Neural Transm Suppl 59 2000 9 14
61. R. Schmidt, H. Schmidt, J.D. Curb, K. Masaki, L.R. White, and L.J. Launer Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study Ann Neurol 52 2002 168 174
62. R. Schmidt, C. Enzinger, S. Ropele, H. Schmidt, and F. Fazekas Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study Lancet 361 2003 2046 2048
63. R. Schmidt, Ph. Scheltens, T. Erkinjuntti, L. Pantoni, H.S. Markus, and A. Wallin White matter lesions progression: a surrogate endpoint for trials in cerebral small vessel disease Neurology 63 2004 139 144
64. A. Semplicini, G. Meneghetti, F. Chierichetti, B. Saitta, C. Simonella, and S. Bongiovì SPECT evaluation of cerebral perfusion in uncomplicated essential hypertension and effects of enalapril Cerebrovasc Dis 4 1994 354 358
65. A. Semplicini, A. Maresca, M. Sartori, L. Calo, and A.C. Pessina Hypertension and cerebrovascular diseases: a specific role of vascular protection in the prevention of dementia J Cardiovasc Pharmacol 38 Suppl 2 2001 S79 S82
66. J.R. Simon, and A.P. Rudell Auditory S-R compatibility: the effect of an irrelevant cue on information processing J Appl Psychol 51 1967 300 304
67. I. Skoog, B. Lernielt, and S. Landahl 15-years longitudinal study of blood pressure and dementia Lancet 349 1997 151 154
68. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and clinical expression of Alzheimer disease. The Nun Study JAMA 277 1997 813 817
69. T.E. Strandberg, and R.S. Tilvis C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly Arterioscler Thromb Vasc Biol 20 2000 1057 1060
70. J.R. Stroop Studies of interference in serial verbal reactions J Exp Psychol 18 1935 643 662
71. G.E. Swan, C. DeCarli, B.L. Miller, T. Reed, P.A. Wolf, and L.M. Jack Association of midlife blood pressure to late-life cognitive decline and brain morphology Neurology 51 1998 986 993
72. P. Talelli, J. Ellul, G. Terzis, N.P. Lekka, G. Gioldasis, and A. Chrysanthopoulou Common carotid artery intima media thickness and post-stroke cognitive impairment J Neurol Sci 223 2004 129 134
73. E.B. Titianova, I.V. Velcheva, and P.S. Mateev Effects of aging and hematocrit on cerebral blood flow velocity in patient with unilateral cerebral infarctions: a Doppler ultrasound evaluation Angiology 44 1993 100 106
74. F.J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, and M. Desvarieux Manheim intima-media thickness consensus Cerebrovasc Dis 18 2004 346 349
75. F. Turnbull Blood Pressure Lowering Trialists' Collaboration Effects of different blood pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535
76. C. Tzourio, C. Anderson, N. Chapman, M. Woodward, B. Neal, S. Mac Mahon PROGRESS Collaborative Group Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch Intern Med 163 2003 1069 1075
77. A.H. Vagnucci, and W.W. Li Jr. Alzheimer's disease and angiogenesis Lancet 361 2003 605 608
78. J. Veldink, P. Scheltens, and C. Jonker Progression of cerebral white matter hyperdensities on MRI is related to diastolic blood pressure Neurology 51 1998 319 320
79. L.O. Wahlund, F. Barkhof, F. Fazekas, L. Bronge, M. Augustin, and M. Sjogren A new rating scale for age-related white matter changes applicable to MRI and CT Stroke 32 2001 1318 1322
80. S.R. Waldstein, and L.I. Katzel Hypertension and cognitive function S.R. Waldstein M.F. Elias Neuropsychology of Cardiovascular Disease 2001 Erlbaum Mahwah, NJ 15 36
81. T.J. Wang, B.H. Nam, P.W. Wilson, P.A. Wolf, D. Levy, and J.F. Polak Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study Arterioscler Thromb Vasc Biol 22 2002 1662 1667
82. M.W. Webster, M.S. Makaroun, D.L. Steed, H.A. Smith, D.W. Johnson, and H. Yonas Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease J Vasc Surg 21 1995 338 344
83. L. Wei, J.P. Erinjeri, C.M. Rovainen, and T.A. Woolsey Collateral growth and angiogenesis around cortical stroke Stroke 32 2001 2179 2184
84. H. Yonas, H.A. Smith, S.R. Durham, S.L. Pentheny, and D.W. Johnson Increased stroke risk predicted by compromised cerebral blood flow reactivity J Neurosurg 79 1993 483 489
85. Z. Zhang, and M. Chopp Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia Trends Cardiovasc Med 12 2002 62 66